Medicare Enrolled
Dr. Francis Senecal, M.D.
Hematology & Oncology · Tacoma, WA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Senecal from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Senecal?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Senecal
Dr. Francis Senecal is a hematology & oncology specialist in Tacoma, WA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Senecal performed 69,462 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Senecal received a total of $21,676 from 37 pharmaceutical and/or device companies across 121 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Senecal is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 5% volume in WA
$21,676 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗69,462
Medicare services
Top 5% in WA for hematology & oncology
Not available
Unique patients (not deduplicated)
$12
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
15,300 | $0 | $2 |
| Filgrastim injection (Nivestym) for white blood cells An injection of the biosimilar medication filgrastim-aafi (Nivestym) at a dose of 1 microgram. |
13,620 | $0 | $2 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
11,250 | $0 | $0 |
| Pembrolizumab injection (Keytruda) | 9,600 | $43 | $80 |
| Denosumab injection (Prolia/Xgeva) | 5,220 | $18 | $35 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,682 | $7 | $16 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,455 | $8 | $13 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
1,344 | $10 | $21 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,320 | $0 | $2 |
| Anti-nausea injection (Aloxi/palonosetron) | 790 | $1 | $2 |
| Anti-nausea injection (ondansetron/Zofran) | 685 | $0 | $1 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
630 | $92 | $215 |
| Flow cytometry, additional marker An additional marker is tested during a flow cytometry procedure to analyze DNA or cells. This step adds specific data points to the initial analysis. |
573 | $19 | $65 |
| Pegfilgrastim-apgf injection An injection of pegfilgrastim-apgf, a biosimilar medication. The dose specified is 0.5 mg. |
504 | $104 | $343 |
| Immunoglobulin level test A blood test that measures the level of gammaglobulins, which are immune system proteins. |
459 | $9 | $15 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
339 | $99 | $306 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
317 | $12 | $52 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
316 | $11 | $52 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
261 | $58 | $146 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
249 | $9 | $34 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
244 | $5 | $11 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
229 | $1 | $2 |
| Enhanced Oncology Model monthly payment This code represents the monthly enhanced oncology services payment under the Enhancing Oncology Model. It covers the administrative payment for enhanced services provided to eligible patients. |
195 | $69 | $70 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
170 | $22 | $75 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
166 | $6 | $23 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
142 | $23 | $75 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
135 | $47 | $150 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
135 | $2 | $6 |
| Direct bilirubin level test A blood test that measures the amount of direct bilirubin in your body. Direct bilirubin is the form of the waste product processed by the liver. |
117 | $5 | $11 |
| Glutamyltransferase (GGT) level test A blood test that measures the level of the liver enzyme glutamyltransferase (GGT) to help evaluate liver health. |
116 | $6 | $13 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
111 | $61 | $148 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 109 | $20 | $55 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
103 | $1 | $1 |
| Magnesium sulfate injection, per 500 mg An injection of magnesium sulfate administered in 500 mg increments. |
100 | $1 | $1 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
97 | $24 | $114 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
97 | $2 | $3 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 95 | $132 | $370 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
92 | $45 | $144 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
91 | $4 | $8 |
| Total cortisol level test A blood test that measures the total amount of cortisol hormone in your body. Cortisol is a hormone produced by the adrenal glands. |
90 | $15 | $33 |
| Free thyroxine (T4) test A blood test that measures the level of free thyroxine, a thyroid hormone, in the bloodstream. |
89 | $9 | $19 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
75 | $27 | $100 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
74 | $16 | $34 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
68 | $13 | $28 |
| Iron level test | 54 | $6 | $13 |
| Transferrin level test A blood test that measures the amount of transferrin, a protein that binds to and transports iron in the body. |
54 | $12 | $26 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
49 | $16 | $48 |
| PSA test (prostate cancer screening) | 48 | $18 | $37 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
43 | $29 | $119 |
| Blood sample collection from implanted device This procedure involves drawing a blood sample directly from a medical device that has been surgically placed in the body. |
41 | $20 | $43 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
39 | $17 | $55 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
36 | $1 | $7 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
34 | $117 | $331 |
| Phosphate level test A blood test that measures the amount of phosphate in your body. Phosphate is a mineral that helps keep bones and teeth strong. |
31 | $5 | $10 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
29 | $139 | $292 |
| Urinalysis with microscopic exam A urine test performed manually that includes examining the sample under a microscope to check for abnormalities. |
27 | $2 | $6 |
| New patient office visit, complex (60-74 min) | 26 | $169 | $415 |
| Flow cytometry DNA or cell analysis, first marker A laboratory test that uses a laser to analyze cells or DNA by detecting a specific marker on the cell surface or within the cell. |
25 | $58 | $140 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
24 | $15 | $31 |
| Folic acid level test A blood test that measures the amount of folic acid in the serum. |
17 | $14 | $30 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
17 | $102 | $276 |
| SARS-CoV-2 immunoassay test A laboratory test using immunoassay techniques to detect the presence of severe acute respiratory syndrome coronavirus. |
14 | $32 | $84 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
23.7% high complexity
63.9% medium
12.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$21,676
Total received (2018-2024)
Avg $3,097/year across 7 years
Top 16% in WA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
37
Companies
121
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,447
2023
$9,380
2022
$48
2021
$5,170
2020
$84
2019
$2,295
2018
$3,253
Payments by company (2024)
GlaxoSmithKline, LLC.
$1,200
Merck Sharp & Dohme LLC
$79
AstraZeneca Pharmaceuticals LP
$57
ABBVIE INC.
$37
Ipsen Biopharmaceuticals, Inc
$26
Daiichi Sankyo Inc.
$19
Lilly USA, LLC
$14
Novartis Pharmaceuticals Corporation
$14
Top 3 companies account for 92.3% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$10,156
Kite Pharma, Inc.
$4,730
Novartis Pharmaceuticals Corporation
$3,797
PFIZER INTERNATIONAL LLC
$1,001
Janssen Scientific Affairs, LLC
$340
E.R. Squibb & Sons, L.L.C.
$233
Astellas Pharma US Inc
$220
Pharmacyclics LLC, An AbbVie Company
$146
AstraZeneca Pharmaceuticals LP
$111
Merck Sharp & Dohme LLC
$79
PFIZER INC.
$75
Gilead Sciences, Inc.
$66
Exelixis Inc.
$64
Genentech USA, Inc.
$53
EMD Serono, Inc.
$52
Lilly USA, LLC
$46
Dova Pharmaceuticals
$45
ABBVIE INC.
$37
MEDIVATION FIELD SOLUTIONS LLC
$34
Janssen Biotech, Inc.
$34
Seattle Genetics, Inc.
$32
Spectrum Pharmaceuticals Inc.
$31
Ipsen Biopharmaceuticals, Inc
$26
Amgen Inc.
$25
Incyte Corporation
$25
AbbVie Inc.
$24
Pharmacyclics LLC, an AbbVie Company
$23
AbbVie, Inc.
$23
Janssen Pharmaceuticals, Inc
$21
GENZYME CORPORATION
$19
Daiichi Sankyo Inc.
$19
Celgene Corporation
$18
Aurobindo Pharma USA, Inc.
$18
Coherus Biosciences Inc.
$15
Regeneron Healthcare Solutions, Inc.
$14
Genentech, Inc.
$13
Kyowa Kirin, Inc.
$12
Top 3 companies account for 86.2% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · BESPONSA · BOSULIF · Bavencio · CABOMETYX · CHANTIX · Cabometyx · DARZALEX · Doptelet · EMPLICITI · ENHERTU · EPKINLY · Enhertu · Folotyn · IMBRUVICA · IMFINZI · INLYTA · Imbruvica · KEYTRUDA · KISQALI · LIBTAYO · LORBRENA · LUTATHERA · LYNPARZA · MONJUVI · Nplate · OJJAARA · OPDIVO · Onivyde · PIQRAY · PROMACTA · Padcev · Perjeta · Reblozyl · SANCUSO · SPRYCEL · SUTENT · TAGRISSO · TUMOR LYSIS SYNDROME - DISEASE · Tecentriq · Udenyca · VENCLEXTA · VERZENIO · VOTRIENT · Venclexta · XARELTO · XTANDI · Yescarta
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
52
County median income
$96,632
Nearest hospital to ZIP centroid (approximate)
ST JOSEPH MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Senecal is a mixed practice specialist, with above-average Medicare volume (top 5% in WA), with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Senecal experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Senecal performed 15,300 iron infusion (feraheme) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Senecal receive payments from pharmaceutical companies?
Yes. Dr. Senecal received a total of $21,676 from 37 companies across 121 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Senecal's costs compare to other hematology & oncology specialists in Tacoma?
Dr. Senecal's average Medicare payment per service is $12. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Senecal) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Tacoma
Browse hematology & oncology specialists in Tacoma ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in WA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in WA
Which WA hematology & oncology specialists receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
Kite Pharma, Inc. Payments to Doctors
See all physicians who received payments from Kite Pharma, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology